Brain Cancer Diagnostics Market Analysis and Forecast to 2031: By Test Type (Magnetic Resonance Spectroscopy, PET Scan, Single Photon Emission CT scan, Spinal Tap, MRI), Cancer Type (Acoustic Neuroma, Astrocytoma, Chordomas, Ependymomas), End User (Hospit

Brain Cancer Diagnostics Market Analysis and Forecast to 2031: By Test Type (Magnetic Resonance Spectroscopy, PET Scan, Single Photon Emission CT scan, Spinal Tap, MRI), Cancer Type (Acoustic Neuroma, Astrocytoma, Chordomas, Ependymomas), End User (Hospitals, Cancer Diagnostic Center, Cancer Research Institutes), and Region

The global brain cancer diagnostics market was valued at USD 1639.1 million in 2021 and it is anticipated to grow further till USD 20116.4 million by 2031, at a CAGR of 28.5% during the forecast period.

Extracellular growth in the brain, such as primary and secondary brain tumors, is referred to as brain cancer. While secondary tumors or metastases are those that are brought on by cancers that started in another region of the body, primary brain tumors originate in the brain and do not spread to other parts of the body. There are 40 different varieties of brain tumors that can be classified, and these types are divided into two main categories: benign tumors, which are slow-growing and less prone to spread, and cancerous tumors, which are more likely to do so. There are various factors that lead to brain cancer and are more prevalent in people with particular hereditary or gene disorders.
Global Brain Cancer Diagnostics Market Scope and Report Structure
Market Trends and Drivers
It is anticipated that factors like technological breakthroughs from traditional procedures will fuel revenue growth in the brain cancer diagnostics market. The diagnostic equipment's speed and accuracy have both increased as a result, producing improved results that may finally allow for the earlier use of medicines. Global brain cancer prevalence is predicted to significantly rise in the coming years, supporting market expansion. Increased cigarette smoking and other environmental pollutants, which cause brain cancer, are one of the main contributing factors. This year, there are projected to be 78,000 new primary brain tumour diagnoses, of which 53,000 are non-malignant and 25,000 are malignant.
Market Restraints and Challenges
The main obstacles are the escalating expense of diagnosis, the lack of awareness, and the limited accessibility to the same. In this aspect, affluent markets have substantially greater diagnostic rates than low-income nations.

Global Brain Cancer Diagnostics Market Segmental Overview
The report analyses the global brain cancer diagnostics market based on the test type, cancer type, end user, and region.

Global Brain Cancer Diagnostics Market by Test Type


Based on the test type, it is segmented into magnetic resonance spectroscopy, PET scan, single photon emission CT scan, spinal tap, and magnetic resonance imaging. The magnetic resonance spectroscopy segment is anticipated to dominate the market during the forecast period. The market size of the segment has been impacted by the increase in cigarette smokers who are at risk of developing brain cancer. However, significant obstacles include high diagnostic costs, little awareness, and limited accessibility.

Global Brain Cancer Diagnostics Market by Cancer Type


Based on Cancer type, it is segmented into the acoustic neuroma, astrocytoma, chordoma, and ependymomas. The acoustic neuroma segment is anticipated to dominate the market during the forecast period. Deep learning is a subset of artificial intelligence that trains convolutional neural networks, which are sophisticated mathematical algorithms, to extract features from data. The system can recognize patterns and carry out tasks like picture analysis thanks to this training. The researchers started to run algorithm training on the brain tumor tissue images generated by the SRH imager to combine the potent capabilities of the SRH imager with AI.

Global Brain Cancer Diagnostics Market by End User


Based on the end user, it is segmented into hospitals, cancer diagnostic center, and cancer research institutes. The hospitals segment is anticipated to dominate the market during the forecast period. Technological advancements and advancements in diagnostic equipment are predicted to be the market size drivers for the expansion of brain cancer diagnostics. Additionally, in the approaching years, the significance of the growth in brain cancer is anticipated to increase on a global scale.
Geographical Analysis of the Global Brain Cancer Diagnostics Market

Region-wise, it is studied across the North America, Europe, Asia Pacific, and the Rest of the World. The North American region is anticipated to dominate the market during the forecast period. Due to the availability of reimbursement facilities, increased diagnostic rates are anticipated across Eastern and Western Europe. The market for brain cancer diagnostics is anticipated to benefit from an increase in the quality of healthcare services in Asia Pacific nations. The rise in healthcare costs brought on by government spending plans may raise the bar for diagnostic infrastructure in Asia Pacific nations. China, India, Australia, New Zealand, and South Korea are among the Asian nations that are anticipated to show the most promise due to increased per capita healthcare spending and significant infrastructure improvements.
Major Players in the Global Brain Cancer Diagnostics Market
The key players studied in the report are THERMO FISHER SCIENTIFIC INC, Siemens Healthineers AG, GE Healthcare, MDxHealth, NantOmics, Biocept, Inc., Koninklijke Philips N.V., Canon Medical Systems, Hitachi, Ltd, and Neusoft Medical Systems among others.
COVID-19 Impact
Resources for people with diseases like cancer were diverted by the COVID-19 epidemic. At the start of the COVID-19 crisis, the market for brain cancer diagnostics saw some shortages as a result of factors such supply chain disruption and demand due to the absence of lockdown indicated by the majority of governments. The COVID-19 pandemic had a detrimental effect on cancer patients since so many of them were immunosuppressed and elderly. Additionally, several clinics globally experienced delays with cancer follow-up or imaging appointments. Delays in new cancer diagnosis were caused by delaying normal screening exams. The COVID-19 pandemic caused a delay in cancer detection, which led to a rise in cancer-related death.
Frequently Asked Questions
Q1. How big is the Brain Cancer Diagnostics market?

Ans. The global Brain Cancer Diagnostics market size was USD 1639.1 million in 2021 and it is anticipated to grow further till USD 20116.4 million by 2031, at a CAGR of 28.5% from 2022 to 2031.

Q2. What is the Brain Cancer Diagnostics market growth rate?

Ans. The growth rate of the Brain Cancer Diagnostics market is 28.5%.

Q3. Which region holds a major market share for the Brain Cancer Diagnostics market?

Ans. North America holds a major market share of the Brain Cancer Diagnostics market in 2021.

Q4. Which segment accounted for the largest Brain Cancer Diagnostics market share?

Ans. By end user, the hospitals segment accounted for the largest Brain Cancer Diagnostics market share.

Q5. Who are the key players in the Brain Cancer Diagnostics market?

Ans. The global Brain Cancer Diagnostics market report includes players such as THERMO FISHER SCIENTIFIC INC, Siemens Healthineers AG, GE Healthcare, MDxHealth, NantOmics, Biocept, Inc., Koninklijke Philips N.V., Canon Medical Systems, Hitachi, Ltd, and Neusoft Medical Systems among others.

Q6. What are the factors driving the Brain Cancer Diagnostics market growth?

Ans. The major factors driving the growth of the market are the growing healthcare market in emerging countries.

Q7. What are the key growth strategies of Brain Cancer Diagnostics market players?

Ans. The key growth strategies of Brain Cancer Diagnostics market players are product launch and product approval.

Q8. Which region will provide more business opportunities for the Brain Cancer Diagnostics market during the forecast period?

Ans. The Asia-Pacific region will provide more business opportunities for the Brain Cancer Diagnostics market during the forecast period.

Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.